Top Markets
Coin of the day
Entheon Biomedical Corp. Entheon Biomedical Corp.

Entheon Biomedical Corp.

ENBI
Rank in Stocks #38407
Entheon Biomedical Corp. functions as a biotechnology firm focused on the... Entheon Biomedical Corp. functions as a biotechnology firm focused on the research and development of novel pharmaceuticals. The company is actively involved in pioneering and introducing to market psychedelic therapeutic products, specifically those derived from N,N-dimethyltryptamine (DMT), with the aim of combating addiction and various substance use disorders. Its services are provided to medical doctors, healthcare facilities, and accredited psychiatrists across Canada, the United States, and the European Union. Entheon Biomedical Corp.'s primary operations are based in Vancouver, Canada.
Share Price
$0.0719818
Last synced: 2026-01-15
Market Cap
$997.59K
Change (1 day)
-0.09%
Change (1 year)
4.67%
Country
CA
Trade Entheon Biomedical Corp. (ENBI)

Category

Operating Margin for Entheon Biomedical Corp. (ENBI)
Operating Margin as of 2026 TTM: 0.00%
According to Entheon Biomedical Corp. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Entheon Biomedical Corp. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.